Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-lapse notice and the older Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T09:23:33.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice was added at the top of the page, warning that information may not be up to date and that the NIH Clinical Center is open, and the site revision label was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T05:36:28.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added Show glossary option and a new 'Last Update Submitted that Met QC Criteria' label. Updated capitalization of 'No FEAR Act Data' and the page revision to v3.4.0 (from v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-28T03:58:07.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the prior Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T03:13:01.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section listing Texas as a study location. Replaced the old standalone 'Texas Locations' item with the consolidated Locations section.
    Difference
    0.2%
    Check dated 2025-12-23T21:15:13.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Minor editorial wording changes were made to the Publications section to describe automatic PubMed content, and a page revision version notice was updated. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:52:32.000Z thumbnail image

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.